Abstract
Curcumin (CCM) is a biomolecule with immense potential in the clinical-therapeutic realm due to its notable properties: anti-inflammatory, antimicrobial, antitumor, and antioxidant. Nevertheless, it exhibits poor solubility in aqueous environments, resulting in limited bioavailability upon administration into the bloodstream. To harness its therapeutic attributes, a nanobiotechnological a…